Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
The cave was pitch black – so to create this magical underwater shot, the photographer had to use all his camera expertise... - 2A volcanic eruption may have catalyzed the plague's arrival in Europe, study suggests
- 315 Outrageous Cosplay Outfits That Will Blow You Away
- 4CDC vaccine panel votes to remove universal hepatitis B birth dose recommendation
- 5Investigate These Retreats Well known With Seniors
- Swap The Amalfi Coast For This Low-Cost Ligurian Seaside Town
- Two Indonesian UN peacekeepers killed in explosion in Lebanon
- Vial marked 'Polonium 210' sparks scare during German Easter egg hunt
- They relied on marijuana to get through the day. But then days felt impossible without it
- Smuggler who called migrants 'chickens' jailed
- How to watch 2026 Golden Globe winners like 'One Battle After Another,' 'Adolescence' and 'The Pitt'
- Closets for Your Room: Plan and Utility Features
- Emergency services search for five people last seen in missing Jeep
- Transcript: Scott Gottlieb on "Face the Nation with Margaret Brennan," Dec. 7, 2025
